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Background
An expandable polytetrafluoroethylene (ePTFE) covered 
stent (GRAFTMASTER RX, Abbott Vascular Instruments, 
Abbott Park, IN, USA) is a sealing stent employed for coro-
nary artery perforation [1] and saphenous vein graft lesions 
[2, 3]. Since an ePTFE covered stent is mainly used in the 
emergency cases, its frequency is relative low. Neointimal 
coverage and endothelialization after ePTFE covered stent 
implantation or its clinical time course has not been fully 
reported. Here, we report a case with coronary artery per-
foration treated with an ePTFE covered stent and followed 
up using coronary angiography, optical coherence tomog-
raphy (OCT) and angioscopy 9 months after implantation.
Case report
The patient was a 78-year-old man, who previously suf-
fered from acute myocardial infarction and received a 
bare metal stent implantation at the right coronary artery 
in January, 2013. Since coronary angiography showed a 
moderate stenosis in the left anterior descending artery 
(LAD), he underwent stress myocardial perfusion scin-
tigraphy with thallium, resulting in redistribution in the 
anterior septal wall area. In August, 2013, percutaneous 
coronary intervention (PCI) was performed at the cul-
prit lesion. The culprit lesion was tortuous and angu-
lated. Moreover vessel size tapered distally (Fig.  1a). 
Two EESs (everolimus eluting stents; Xience expedition 
3.0 × 33 mm, 3.5 × 18 mm, Abbott Vascular Instruments, 
Abbott Park, IN, USA) were successfully implanted to 
cover the lesion in the LAD and distal stent area includ-
ing the overlapping segment of EESs was additionally 
dilated with a 3.5-mm stent delivery balloon. However, 
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after balloon inflation, angiography confirmed the pres-
ence of Type III coronary perforation (contrast stream-
ing or cavity spilling) at distal stent site  (Fig.  1b). The 
perfusion balloon was inflated for 30  min, however, 
coronary angiography showed residual Type II per-
foration. Therefore, immediately, the area of perfora-
tion was sealed with the use of an ePTFE covered stent 
3.0 × 16  mm (Fig.  1c). The patient was discharged on 
the 12th hospital day and antiplatelet drugs (aspirin 100-
mg and 75-mg clopidogrel, daily) were continuously 
prescribed. Follow-up coronary angiography 9  months 
after ePTFE covered stent implantation depicted favora-
ble stent patency (Fig.  1d). Thin and uneven stent strut 
coverage by neointimal coverage in the single EES strut 
was detected by optical coherence tomography (OCT), 
while partial tissue coverage in the ePTFE covered stent 
strut was detected (Fig. 1e1–3). The images obtained by 
angioscopy were similar to those of OCT; the ePTFE 
covered stent strut was partially coated by white tissue 
or exposed. No obvious silent stent thrombus was found 
(Fig.  1f1–3). In this case, the patient had an uneventful 
clinical course beyond 3 years.
Fig. 1  a Severe stenosis was depicted at the left anterior dissent-
ing artery. b Coronary perforation after stent implantation (yel-
low arrow). 1, 2 Everolimus eluting stent (EES). c Post expandable 
polytetrafluoroethylene (ePTFE) covered stent implantation (3). d 
Coronary angiograms 9  months after stent implantation. e1 Optical 
coherence tomographic images at the middle of proximal EES. The 
EES struts are completely covered by neointima. At the middle of 
ePTFE stent. The double and triple stent struts can be observed. (e2) 
depicts uneven and partial coverage, whereas (e3) shows no circum-
ferential coverage. Angioscopic images of ePTFE covered stent and 
EES struts. f1 The EES is completely covered by white neointima; 
however, the strut is translucently identified. f2 Partial coverage with 





In this case, OCT and angioscopy depicted the thinly 
coated ePTFE covered stent strut with white tissue. It is 
quite challenging to distinguish this coverage, neointima 
or organized thrombus. The surface of fresh fibrin throm-
bus is generally not smooth [4]. In this case, OCT depicted 
the smooth surface, suggesting that it might be neointimal 
coverage or organized thrombus. Moreover, the absence 
of obvious white or red thrombi in the ePTFE covered 
stent supported our theory. The neointimal coverage was 
observed in the most part of the overlapping EES struts, 
whereas partial and thin coverage or strut exposure was 
found in the ePTFE stent strut. An ePTFE covered stent 
might be delayed the neointimal coverage compared to EES 
because it might inhibit smooth muscle cell migration in 
the stent strut. According to previous report, thromboem-
bolism might possibly occur 9 months after ePTFE covered 
stent implantation. Therefore, the long-term therapy with 
antiplatelet drugs or anticoagulants is thus required in such 
cases. RECOVERS trial [3] was a randomized and mul-
ticenter trial to evaluate the usefulness of an ePTFE cov-
ered stent compared with a bare metal stent in the saphen-
ous vein graft lesions. No differences in binary stenosis or 
target lesion revascularization were found between ePTFE 
covered stents and bare metal stents, although, the 6-month 
non-Q-wave myocardial infarction rate was significantly 
higher in the lesions treated with ePTFE covered stents. 
Moreover, it reported the occurrence of subacute thrombo-
sis in two patients treated with ePTFE covered stents. In the 
RECOVERS trial, dual antiplatelet therapy (DAPT) was 
mandatory to take only for 3 months; then, the single use 
of aspirin was continuously prescribed after the termination 
of DAPT. Considering uneventful clinical course beyond 
3 years in this case, it may be recommended to avoid stent 
thrombosis after artificial covered stent deployment. Given 
the paucity of data, the optimal duration of DAPT after 
implantation of ePTFE covered stent should be assessed in 
future studies.
Conclusion
This is the rare case report observed using coronary imag-
ing 9  months after ePTFE covered stent implantation. 
Although the type and optimal duration of dual antiplatelet 
therapy (DAPT) for patients undergoing an ePTFE implant 
has not been studied, longer DAPT should be recom-
mended for preventing stent thrombosis after ePTFE cov-
ered stent implantation.
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